[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:sgsh-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"SGSH Gene",3,2,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT02716246","Phase I\u002FII\u002FIII Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH",[12],"Phase 2\u002FPhase 3","RECRUITING","2026-08-26T02:17:52.450442Z","2026-05-05T02:43:28.741288Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06614894","An Open Label Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacologic Properties of High Dose Ambroxol Hydrochloride in Adult (≥ 18 Years of Age) Subjects With MPS III",[12],"2026-08-26T02:16:27.227548Z","2026-04-29T02:57:57.067665Z",{"nct_id":23,"title":24,"phases":25,"status":27,"updated_at":28,"content_modified":29},"NCT04542161","Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis\u002FChronic Fatigue Syndrome",[26],"Phase 2","ACTIVE_NOT_RECRUITING","2026-08-03T02:33:50.324958Z","2026-05-05T02:43:27.658729Z"]